News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer
Laura Bukavina/X
Jan 23, 2025, 02:31

Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X:

“JCOG1019 trial compared 8 doses of BCG vs. no treatment in HG T1 bladder cancer patients with pT0 reTURBT.

5-year RFS: 87% (BCG) vs. 82% (no treatment). Metastasis rates: 15% (BCG) vs. 21% (no treatment).

My Conclusion: 8 doses of BCG =insufficient; maintenance is critical.”

Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer

Additional information

cancer Laura Bukavina OncoDaily Oncology
Special Coverage
Science
Mar 3, 2025, 15:58
Esranur Aydın: Metastatic IDH2-mutant cholangiocarcinoma treated with venetoclax and decitabine
Science
Mar 3, 2025, 15:56
Selpercatinib in RET Fusion-Positive NSCLC by Oliver Gautschi et al.
Blog
Mar 3, 2025, 15:54
Jihan Azar: Childhood Cancer Inequalities in the WHO Eastern Mediterranean Region
Insight
Mar 3, 2025, 15:53
Arthur Sun Myint: Beacon of hope for patients with rectal cancer wishing to avoid major surgery and a stoma
Blog
Mar 3, 2025, 15:53
Toufic Kachaamy: Aasma Shaukat on how AI might accelerate precision medicine initiatives for CRC prevention
Blog
Mar 3, 2025, 15:52
Magdalena Skipper: An assault of science and scientists anywhere is an assault on science and scientists everywhere
Science
Mar 3, 2025, 15:51
Patrick Hwu: Are B cells important to eliminate cancers?
Blog
Mar 3, 2025, 15:50
Wafaa Rashed: Honored to feature Dr. Mary Relling in PAPERI Bright Minds Series episode
Blog
Mar 3, 2025, 15:49
Wafik El-Deiry: Discussing Legorreta Cancer Center's programmatic leadership
Blog
Mar 3, 2025, 15:48
Registration is open for the ASCO-Endorsed CPOEM Foundation Webinar
Insight
Mar 3, 2025, 15:47
Jill Feldman: ASCO's updated living guidelines for treating stage IV NSCLC
Blog
Mar 3, 2025, 15:47
Uta Dirksen: We have officially opened the first pediatric oncology ward in Eritrea